242 related articles for article (PubMed ID: 24114764)
1. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
3. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
Umair A; Tarakji B; Ibrahim A; Nasser A; Fq A; Shreen A
Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
6. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
7. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
[TBL] [Abstract][Full Text] [Related]
9. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis.
Teh MT; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Purdie K; Harwood C; Wan H; Odell EW; Hackshaw A; Waseem A
Int J Cancer; 2013 May; 132(9):2095-106. PubMed ID: 23034676
[TBL] [Abstract][Full Text] [Related]
10. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.
Degli Esposti D; Sklias A; Lima SC; Beghelli-de la Forest Divonne S; Cahais V; Fernandez-Jimenez N; Cros MP; Ecsedi S; Cuenin C; Bouaoun L; Byrnes G; Accardi R; Sudaka A; Giordanengo V; Hernandez-Vargas H; Pinto LF; Van Obberghen-Schilling E; Herceg Z
Genome Med; 2017 Apr; 9(1):33. PubMed ID: 28381277
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
12. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
13. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.
Chen K; Sawhney R; Khan M; Benninger MS; Hou Z; Sethi S; Stephen JK; Worsham MJ
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1131-8. PubMed ID: 18025318
[TBL] [Abstract][Full Text] [Related]
14.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
16. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
17. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
Roh V; Hiou-Feige A; Misetic V; Rivals JP; Sponarova J; Teh MT; Ferreira Lopes S; Truan Z; Mermod M; Monnier Y; Hess J; Tolstonog GV; Simon C
J Pathol; 2020 Jan; 250(1):107-119. PubMed ID: 31465124
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation association with stage progression of head and neck squamous cell carcinoma.
Ghafarpour V; Khansari M; Banaei-Moghaddam AM; Najafi A; Masoudi-Nejad A
Comput Biol Med; 2021 Jul; 134():104473. PubMed ID: 34034219
[TBL] [Abstract][Full Text] [Related]
20. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]